Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131629) titled 'A Multicenter Study of Predicting Renal Cancer Subtypes Using Pathomics of Biopsy Specimens Combined with Radiomics' on Sept. 4.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The Third Medical Centre, Chinese PLA General Hospital, Beijing, China
Condition:
Renal cell carcinoma
Intervention:
Gold Standard:Histopathological results
Recruitment Status: Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-05-04
Target Sample Size: Target condition:160;Difficult condition:1036
Countries of Recruitment:
China
To know more, visit https://www.chi...